WO1993009805A1 - Polar lipid composition of plant origin - Google Patents
Polar lipid composition of plant origin Download PDFInfo
- Publication number
- WO1993009805A1 WO1993009805A1 PCT/FR1992/001048 FR9201048W WO9309805A1 WO 1993009805 A1 WO1993009805 A1 WO 1993009805A1 FR 9201048 W FR9201048 W FR 9201048W WO 9309805 A1 WO9309805 A1 WO 9309805A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- active agent
- composition according
- composition
- lipid
- polar lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
Definitions
- an experimental process was used based on research by measuring the conductivity of the amount of water causing the phase inversion of an emulsion .
- the moisturizing agents present in these compositions can be liposoluble humectants or hygroscopic agents such as for example lanolin, polyunsaturated fatty acids in particular vitamin F, linoleic acid, gammalinolenic acid or eicosapentaenoic acid or alternatively water-soluble agents such as glycerin, mucopolysaccharides, allantoin derivatives, amino acids, urea, sodium, potassium.
- composition in accordance with the invention may also take the form of a medicinal composition intended for various therapeutic classes and the active agent of which may take various forms and in particular be chosen from the group formed by antibiotics, anti-inflammatories, cortidoids, antivirals, anticancer drugs and drugs for cardiovascular pathologies.
- the polar lipid sheath acts as a "decoy" to trap the pathogen and facilitate its elimination.
- Vitamin E acetate 2%
- the principle of this test consists in measuring the inhibition of the enzymatic activity by different preparations tested by following the kinetics at 410 nm of the degradation of a substrate S corresponding essentially to elastin le: Me-O-Suc-Ala 2 -Pro- Val-pNa (N-Methoxysuccinyl-Ala-Ala-Pro-Val-p-Nitroanilide).
- Me-O-Suc-Ala 2 -Pro- Val-pNa N-Methoxysuccinyl-Ala-Ala-Pro-Val-p-Nitroanilide.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5509026A JPH07508496A (en) | 1991-11-15 | 1992-11-12 | Vegetable polar lipid composition |
EP93900242A EP0619741A1 (en) | 1991-11-15 | 1992-11-12 | Polar lipid composition of plant origin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR91/14081 | 1991-11-15 | ||
FR9114081A FR2683721B1 (en) | 1991-11-15 | 1991-11-15 | POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993009805A1 true WO1993009805A1 (en) | 1993-05-27 |
Family
ID=9418967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1992/001048 WO1993009805A1 (en) | 1991-11-15 | 1992-11-12 | Polar lipid composition of plant origin |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0619741A1 (en) |
JP (1) | JPH07508496A (en) |
AU (1) | AU3162293A (en) |
CA (1) | CA2123585A1 (en) |
FR (1) | FR2683721B1 (en) |
WO (1) | WO1993009805A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0662319A1 (en) * | 1994-01-10 | 1995-07-12 | L'oreal | Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use |
WO1997020572A1 (en) * | 1995-12-06 | 1997-06-12 | Synthelabo | Pharmaceutical compositions for oral use including an nsaid and ceramides |
DE19602108A1 (en) * | 1996-01-22 | 1997-07-24 | Beiersdorf Ag | Substances effective against bacteria, parasites, protozoa, mycota and viruses |
FR2747307A1 (en) * | 1996-04-11 | 1997-10-17 | Ravi Shrivastava | Use of ceramide(s), preferably with added magnesium and vitamin E |
WO1998013018A1 (en) * | 1996-09-27 | 1998-04-02 | Unilever Plc | Skin care composition containing an amide and retinol or retinyl ester |
US6165997A (en) * | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
WO2002002074A3 (en) * | 2000-06-30 | 2003-06-12 | Unilever Plc | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3339907A1 (en) * | 1983-11-04 | 1985-05-23 | Karl Eugen Prof. Dr.med. 7302 Ostfildern Theurer | Preparation and therapeutic use of liposome membranes with cytotropism |
EP0278505A2 (en) * | 1987-02-12 | 1988-08-17 | Estee Lauder Inc. | Hair protection composition and method |
WO1989002733A1 (en) * | 1987-09-22 | 1989-04-06 | The Regents Of The University Of California | Liposomal nucleoside analogues for treating aids |
EP0319638A1 (en) * | 1987-12-08 | 1989-06-14 | Estee Lauder Inc. | Liposome containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
GB2213723A (en) * | 1985-07-31 | 1989-08-23 | Kao Corp | Preparing lipids from epidermis horny layer |
WO1989010753A1 (en) * | 1988-05-05 | 1989-11-16 | Amy Louise Tsui Collins | An agent for desensitizing man and/or animals against an allergen |
DE3815473A1 (en) * | 1988-05-06 | 1989-11-16 | Karl Heinz Prof Dr Dr Schmidt | System of active substances for lipid exchange with target structures |
EP0433242A1 (en) * | 1989-10-16 | 1991-06-19 | Fondazione Andrea Cesalpino | Vaccines and process for their preparation |
WO1992021321A1 (en) * | 1991-05-27 | 1992-12-10 | Laboratoires Inocosm | Method for separating a vegetable compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63734A (en) * | 1981-09-04 | 1985-07-31 | Yeda Res & Dev | Lipid fraction,its preparation and pharmaceutical compositions containing same |
JP2519181B2 (en) * | 1987-03-28 | 1996-07-31 | 鐘紡株式会社 | Hair nourishing cosmetics |
FR2609397B1 (en) * | 1988-02-23 | 1991-12-13 | Serobiologiques Lab Sa | USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION |
-
1991
- 1991-11-15 FR FR9114081A patent/FR2683721B1/en not_active Expired - Fee Related
-
1992
- 1992-11-12 WO PCT/FR1992/001048 patent/WO1993009805A1/en not_active Application Discontinuation
- 1992-11-12 CA CA002123585A patent/CA2123585A1/en not_active Abandoned
- 1992-11-12 JP JP5509026A patent/JPH07508496A/en active Pending
- 1992-11-12 AU AU31622/93A patent/AU3162293A/en not_active Abandoned
- 1992-11-12 EP EP93900242A patent/EP0619741A1/en not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3339907A1 (en) * | 1983-11-04 | 1985-05-23 | Karl Eugen Prof. Dr.med. 7302 Ostfildern Theurer | Preparation and therapeutic use of liposome membranes with cytotropism |
GB2213723A (en) * | 1985-07-31 | 1989-08-23 | Kao Corp | Preparing lipids from epidermis horny layer |
EP0278505A2 (en) * | 1987-02-12 | 1988-08-17 | Estee Lauder Inc. | Hair protection composition and method |
WO1989002733A1 (en) * | 1987-09-22 | 1989-04-06 | The Regents Of The University Of California | Liposomal nucleoside analogues for treating aids |
EP0319638A1 (en) * | 1987-12-08 | 1989-06-14 | Estee Lauder Inc. | Liposome containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
WO1989010753A1 (en) * | 1988-05-05 | 1989-11-16 | Amy Louise Tsui Collins | An agent for desensitizing man and/or animals against an allergen |
DE3815473A1 (en) * | 1988-05-06 | 1989-11-16 | Karl Heinz Prof Dr Dr Schmidt | System of active substances for lipid exchange with target structures |
EP0433242A1 (en) * | 1989-10-16 | 1991-06-19 | Fondazione Andrea Cesalpino | Vaccines and process for their preparation |
WO1992021321A1 (en) * | 1991-05-27 | 1992-12-10 | Laboratoires Inocosm | Method for separating a vegetable compound |
Non-Patent Citations (4)
Title |
---|
BRUNKE R. A.: "SPEZIFISCHE EIGENSCHAFTEN VON SPHINGOSOMEN.", SOFW-JOURNAL SEIFEN, OELE, FETTE, WACHSE., VERLAG FUR CHEMISCHE INDUSTRIE, AUGSBURG., DE, vol. 116., no. 02., 1 February 1990 (1990-02-01), DE, pages 51 - 55., XP000136052, ISSN: 0942-7694 * |
DATABASE WPIL Week 8236, Derwent Publications Ltd., London, GB; AN 82-75279 * |
DATABASE WPIL Week 8551, Derwent Publications Ltd., London, GB; AN 85-320787 * |
PATENT ABSTRACTS OF JAPAN vol. 13, no. 49 (C-565)3 Février 1989 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2714829A1 (en) * | 1994-01-10 | 1995-07-13 | Oreal | Cosmetic and / or dermatological composition for the treatment of aging containing ceramides, its use. |
EP0662319A1 (en) * | 1994-01-10 | 1995-07-12 | L'oreal | Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use |
US6056944A (en) * | 1995-12-06 | 2000-05-02 | Synthelabo | Pharmaceutical compositions for oral use including an NSAID and ceramides |
WO1997020572A1 (en) * | 1995-12-06 | 1997-06-12 | Synthelabo | Pharmaceutical compositions for oral use including an nsaid and ceramides |
FR2742054A1 (en) * | 1995-12-06 | 1997-06-13 | Synthelabo | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-INFLAMMATORY AGENT AND VEGETABLE CERAMIDES |
DE19602108A1 (en) * | 1996-01-22 | 1997-07-24 | Beiersdorf Ag | Substances effective against bacteria, parasites, protozoa, mycota and viruses |
FR2747307A1 (en) * | 1996-04-11 | 1997-10-17 | Ravi Shrivastava | Use of ceramide(s), preferably with added magnesium and vitamin E |
WO1998013018A1 (en) * | 1996-09-27 | 1998-04-02 | Unilever Plc | Skin care composition containing an amide and retinol or retinyl ester |
US5955092A (en) * | 1996-09-27 | 1999-09-21 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester |
US6165997A (en) * | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
WO2002002074A3 (en) * | 2000-06-30 | 2003-06-12 | Unilever Plc | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
US7959913B2 (en) | 2000-06-30 | 2011-06-14 | Conopco, Inc. | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
US8226933B2 (en) | 2000-06-30 | 2012-07-24 | Unilever Home & Personal Care, Usa Division Of Conopco, Inc. | Method for treating skin with booster compositions |
US8409550B2 (en) | 2000-06-30 | 2013-04-02 | Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. | Method for treating skin with retinoids and retinoid boosters |
Also Published As
Publication number | Publication date |
---|---|
CA2123585A1 (en) | 1993-05-27 |
JPH07508496A (en) | 1995-09-21 |
FR2683721A1 (en) | 1993-05-21 |
EP0619741A1 (en) | 1994-10-19 |
FR2683721B1 (en) | 1995-06-09 |
AU3162293A (en) | 1993-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0661037B1 (en) | Composition against skinaging acting simultaneously on the superficial and deep skinlayers | |
JP2020515635A (en) | Pharmaceutical composition | |
Hsieh et al. | Improved skin permeability and whitening effect of catechin-loaded transfersomes through topical delivery | |
WO2002076506A1 (en) | Use of lipoaminoacids as absorption promoters in a pharmaceutical composition | |
FR2822381A1 (en) | New superoxide dismutase compositions, used for e.g. prevention and treatment allergies, inflammatory disorders, and degenerative disorders, comprise Cucumis melo extract and a liposoluble fatty material | |
EP0491921B1 (en) | Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance | |
CA2878496C (en) | Use of a myrtle extract as an anti-biofilm agent against p. acnes | |
FR2956320A1 (en) | NANOEMULSION FOR THE ISSUE OF AT LEAST TWO AGENTS OF INTEREST | |
CA2176511C (en) | Biologically active silicon compounds and their therapeutic and cosmetic applications | |
WO1993009805A1 (en) | Polar lipid composition of plant origin | |
KR101732844B1 (en) | Composition for treating or preventing dermatitis comprising anti-inflamatory lipid nano carrier for topical dermal delivery | |
US20120276189A1 (en) | Therapeutic Treatment of Dermatologic Skin Disorders | |
WO2011117547A1 (en) | Oligosaccharide extracted from halymenia durvillaei, method for preparing such an oligosaccharide, and cosmetic use of said oligosaccharide | |
EP2675463B1 (en) | Aqueous ionic solution containing seawater and at least one compound that is originally immiscible with seawater | |
FR2779646A1 (en) | PLANT EXTRACT OF CEREALS BASED ON POLAR LIPIDS AND COSMETIC COMPOSITION COMPRISING SUCH A PLANT EXTRACT | |
US5817646A (en) | Polar lipid composition of plant origin | |
FR2473887A1 (en) | NOVEL USE OF GLUCOSAMINO-GLYCAN BIOCHEMICAL PRECURSORS AND RESPECTIVE PHARMACEUTICAL AND COSMETIC COMPOSITIONS | |
WO2016097618A1 (en) | Use of pll for improving the stability of molecules in solution | |
WO2005061552A1 (en) | Amphiphilic heparin derivative formed by coupling a heparin with a bile acid | |
FR2690343A1 (en) | Compsn. with anti-radical and anti-lipo-peroxidising effect contg. polar lipid - for use in cosmetics, dietetics, food industry and pharmacology | |
WO2019080983A1 (en) | Novel formulation based on chitosan and method for producing same | |
US20240165028A1 (en) | Chitosomes or chitosan-coated liposomes, use thereof to obtain cosmetic or pharmaceutical compositions and preparation method thereof | |
US20090274750A1 (en) | Therapeutic Treatment of Dermatologic Skin Disorders | |
Ricci et al. | Liposome-Based Antioxidant Delivery Systems for Skin Health | |
Jain et al. | Co-administration of Adapalene loaded Nanostructured lipid carriers and Vitamin-E for management of acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993900242 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2123585 Country of ref document: CA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1993900242 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1994 244019 Country of ref document: US Date of ref document: 19941101 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1996 717626 Country of ref document: US Date of ref document: 19960923 Kind code of ref document: A |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993900242 Country of ref document: EP |